CIK 0001080014 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 411.3 M | 331.3 M |
| Diluted EPS (USD/shares) | 3.3 | 2.37 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-24 | 4 | 4 | 2026-08-20 |
| 2026-08-24 | 4 | 4 | 2026-08-20 |
| 2026-08-24 | 4 | 4 | 2026-08-20 |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-22 | 4 | 4 | 2026-05-20 |
| 2026-05-22 | 4 | 4 | 2026-05-20 |
| 2026-05-22 | 4 | 4 | 2026-05-20 |
| 2026-05-20 | 4 | 4 | 2026-05-18 |
| 2026-05-20 | 3 | 3 | 2026-05-18 |
| 2026-05-18 | 8-K | 8-K items 5.02,9.01 | 2026-05-12 |
| 2026-05-13 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-06 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-06 | 8-K | 8-K items 2.02,9.01 | 2026-05-06 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-05-04 | S-8 | S-8 | |
| 2026-05-04 | 8-K | 8-K items 5.07 | 2026-05-04 |
| 2026-04-29 | SCHEDULE 13G | SCHEDULE 13G |
Forms on file (last 1,000): 4 374, 8-K 266, SC 13G/A 50, 10-Q 41, 3 33, SC 13D/A 31, DEFA14A 30, DFAN14A 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=INVA (0.002 USD), /gw/filings/filings?ticker=INVA&form=8-K, /gw/filings/facts?ticker=INVA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange